BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 29, 2025
Home » Authors » Omar Ford

Articles by Omar Ford

Deals roundup: Cardinal Health to acquire AccessClosure for $320M

April 4, 2014
By Omar Ford
The acquisition of AccessClosure (Santa Clara, California) by Cardinal Health (Dublin, Ohio) could be considered as a one of the largest Cinderella stories in med-tech this year. The small private firm, that develops the Mynx family of patient-friendly vascular closure devices, was acquired by Cardinal Health, a $101 billion healthcare services company, for $320 million. News first broke about the acquisition on Wednesday.
Read More

Spiracur gains FDA clearance for SNaP Wound Care Dressing

April 3, 2014
By Omar Ford

Intuitive Surgical gains clearance for da Vinci Xi surgical system

April 2, 2014
By Omar Ford

Nordion to be acquired by Sterigenics for $727 million

April 1, 2014
By Omar Ford

Exact Sciences gains unanimous FDA panel vote for Cologuard

March 31, 2014
By Omar Ford

MDD's Diagnostics Extra

March 28, 2014
By Omar Ford

Industry Deals: Baxter is latest firm to split into two independent companies

March 28, 2014
By Omar Ford
Baxter International (Deerfield, Illinois) dominated med-tech headlines yesterday when it reported its intent to split into two separate and independent companies - one focused on developing biopharmaceuticals and the other focused on developing life-saving medical products. The measure puts to rest weeks of rumors regarding the split.
Read More

Benvenue launches Kiva VCF, unveils results from KAST trial

March 27, 2014
By Omar Ford
Five years of gathering and collecting clinical evidence is paying off for Benvenue Medical (Santa Clara, California). This week the company got to see the size of the payoff, during the annual scientific meeting for the Society for Interventional Radiology (Fairfax, Virginia) held in San Diego.
Read More

DermTech completes validation of its pigmented lesion assay

March 26, 2014
By Omar Ford

St. Jude snags approvals for pacemakers, leads

March 25, 2014
By Omar Ford
Previous 1 2 … 88 89 90 91 92 93 94 95 96 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing